Global /China /Healthcare /Drug Manufacturers - General /603222
chevron_leftBack
Chimin Health Management Co., Ltd. logo

Chimin Health Management Co., Ltd.

603222
SSE: 603222 Delayed
9.80CNY 2.5%
1.45 USD
As of 16 June 2026, Chimin Health Management Co., Ltd. has a market cap of $738.5M USD, ranking #12583 globally and #3765 in China. It ranks #1149 in the Healthcare sector, and #429 in the Drug Manufacturers - General industry.
Global Rank
12583
Country Rank
3765
Sector Rank
1149
Industry Rank
429
Key Stats
Market Cap
$738.5MUSD
5.0B CNY
Enterprise Value
$812.51MUSD
5.5B CNY
Revenue (TTM)
$101.3MUSD
685.96M CNY
EBITDA (TTM)
$1.02MUSD
6.94M CNY
Net Income (TTM)
-$36.27MUSD
-245.58M CNY
EBITDA Margin
1%
Profit Margin
-36%
PS Ratio
7.3
PB Ratio
3.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yunfei Tian open_in_new
Employees
1,994
Founded
1996
Website
chimin.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.5% -7.1% 6.6% 12% -3.6% 63%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
603222
济民健康管理股份有限公司 Class A
ISIN: CNE100002193
Shares Out.:
513.446M1 Shares Float: 508.163M2
TV:
SA:
YF:
GF:
BA:
MS:
9.80 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Chimin Health Management Co., Ltd.

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automated immunoassay monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, hemodialysis tubing, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.89B
364.89B CNY
7K%
44.9
603259
$49.67B
336.36B CNY
7K%
17.2
$28.52B
223.48B HKD
4K%
35.7
$18.8B
147.32B HKD
2K%
162.3
$16.52B
111.89B CNY
2K%
-
9926
$16.01B
125.46B HKD
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
103K%
38.1
JNJ
$547.28B
74K%
26.4
ABBV
$360.63B
49K%
97.4
$322.73B
256.25B CHF
44K%
19.9
AZN
$289.3B
215.59B GBP
39K%
27.6
NOVN
$275.68B
218.9B CHF
37K%
20.5
chevron_leftBack